Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesAlida L.P. Caforio, Perry Elliott, Arsen Ristić et al.|European Heart Journal|2013Cited by 3.4k
2023 ESC Guidelines for the management of cardiomyopathiesElena Arbelo, Ulf Landmesser, Alexandros Protonotarios et al.|European Heart Journal|2023Cited by 2.3k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Artur Oręziak et al.|The Lancet|2020Cited by 1.2k
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic CardiomyopathiesMartín Ortiz-Genga, Lorenzo Monserrat, Sofía Cuenca et al.|Journal of the American College of Cardiology|2016Cited by 472
Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathyGuillermo Luxán, José Luís de la Pompa, Jesús C. Casanova et al.|Nature Medicine|2013Cited by 361